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Malaria-associated acute lung injury/acute respiratory distress syndrome (ALI/ARDS) often results in morbidity and mortality.
Murine models to study malaria-associated ALI/ARDS have been described; we still lack a method of distinguishing which
mice will develop ALI/ARDS before death. This work aimed to characterize malaria-associated ALI/ARDS in a murine model
and to demonstrate the first method to predict whether mice are suffering from ALI/ARDS before death. DBA/2 mice infected
with Plasmodium berghei ANKA developing ALI/ARDS or hyperparasitemia (HP) were compared using histopathology, PaO
2
measurement, pulmonary X-ray, breathing capacity, lung permeability, and serum vascular endothelial growth factor (VEGF)
levels according to either the day of death or the suggested predictive criteria. We proposed a model to predict malaria-associated
ALI/ARDS using breathing patterns (enhanced pause and frequency respiration) and parasitemia as predictive criteria from mice
whose cause of death was known to retrospectively diagnose the sacrificed mice as likely to die of ALI/ARDS as early as 7 days
after infection. Using this method, we showed increased VEGF levels and increased lung permeability in mice predicted to die of
ALI/ARDS. This proposed method for accurately identifying mice suffering from ALI/ARDS before death will enable the use of
this model to study the pathogenesis of this disease.
1. Introduction
Malaria is an infectious disease with a huge impact on public
health and a high mortality rate. According to the World
Health Organization, approximately 3.3 billion people were
at risk of contracting malaria in 2011 [1–3]. In some indi-
viduals, Plasmodium infection may result in severe malaria
that can lead to ALI/ARDS [4, 5]. Patients infected with
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P. falciparum, P. vivax, and P. knowlesi can develop ALI
or ARDS with mortality rates of approximately 80% [6, 7].
Malaria-associated ALI/ARDS is thought to be due, in part,
to increased alveolar permeability, parasite sequestration, and
host immune response; however, the mechanisms behind it
are largely unknown [4].
ALI/ARDS can occur at any time during an infection,
even after treatment with antimalarial drugs when para-
sitemia has been reduced (reviewed in [4]).The development
of ALI/ARDS, along with its negative outcomes, makes the
prospective identification and effective treatment of those
who develop this syndrome very important. Though, there is
little information on malaria-associated ALI/ARDS progres-
sion, resulting in a lack of knowledge of the mechanisms of
pathogenesis; therefore, the understanding of mouse models
is essential.
Several reports have observed lung injury in mice
infected with P. berghei (Pb) strains [8–19]. The observations
have highlighted possible roles for many factors, including
platelet-activating factor receptor [8], urokinase receptor
[9], ICAM-1 [10, 11], CD40 [12], neutrophils [13], vascular
endothelial growth factor (VEGF) [14], epithelium sodium
channel activity [15], CD36-dependent parasite sequestration
[16], hemozoin deposition [17], and CD8+ T lymphocytes
[18], in malaria-associated lung injury.
Recently, there have been many models described that
focus on the pulmonary pathology associated with malaria,
including the classical C57BL/6 susceptible mouse model
of cerebral malaria infection with PbANKA [16, 19]. Other
models have used different parasite/mouse combinations
that result in the mice surviving for longer periods of time
(without signs of cerebral malaria), theoretically allowing the
investigation of disease progression over time [14, 15, 18].
However, none of them were able to identify ALI/ARDS
before death. Here, we have characterized a murine model
of malaria-associated ALI/ARDS that shows similarities
between humans and murine ALI/ARDS. Moreover, we
proposed a method for classifying mice suffering from
ALI/ARDS before the time of death as a predictive model for
malaria-associated ALI/ARDS.
2. Materials and Methods
2.1. Mice and Parasites. DBA/2 male mice 6–10 weeks old
(purchased from the Department of Parasitology, University
of Sa˜o Paulo, Brazil) were infected with 1 × 106 P. berghei
ANKA (clone 1.49 L) infected red blood cells (iRBCs), as pre-
viously described [14]. Parasitemia and mortality were moni-
tored daily. Parasitemia levels were analyzed using Giemsa-
stained peripheral blood smears.
2.2. Anesthesia and Euthanasia. All efforts were made to
prevent undue stress or pain to the mice. Mice with signs
of imminent death were euthanized to avoid suffering.
Before restraint for X-rays, the mice were given ketamine
(100mg/kg) and xylazine (5mg/kg). The mice were eutha-
nized with ketamine (300mg/kg) (Vetbrands, Brazil) and
xylazine (22.5mg/kg) (Syntec, Brazil), and consciousness was
checked by testing the pedal reflex, heartbeats and breathing
movements.
2.3. Histological Evaluations. Necropsy was performed in
mice dying naturally from the malaria or mice sacrificed on
the 20th days after infection (DAI) to complete the exper-
iment and to avoid animal suffering. The lungs were col-
lected, fixed in buffered 10% formalin and then embedded
in paraffin, sectioned at 5𝜇m onto slides and stained with
hematoxylin-eosin (HE) and phosphotungstic acid hema-
toxylin (PTAH), to emphasize fibrin, as previously described
[20].
2.4. Arterial Blood Analyses and Measurements of Body Tem-
perature. Mice were placed near a heat lamp for three
minutes to increase peripheral bloodflow.Themicewere then
restrained by hand, the ventral artery of the tail was nicked
with a small scalpel blade, and capillary tubes containing lith-
ium-heparin (50 IU/mL) were placed underneath the cut to
collect approximately 100 𝜇L of blood. The blood was imme-
diately placed in an i-STAT EG 8+ cartridge and analyzed
using the iSTAT System Analyzer (Abbott group). The
PaO
2
/FiO
2
was calculated assuming that the fraction of
inspired O
2
(FiO
2
) was 0.21. In a subset of mice, the inguinal
temperatures were assessed on day 0 and on the 5th, 7th and
9th DAI using a DT-203/60SEC digital thermometer (Becton
Dickinson, Franklin Lakes, New Jersey, EUA).
2.5. X-Ray. Mice received light anesthesia on the 7thDAI and
were X-rayed for 0.066 seconds in a mA100 fine focus Bucky
V mAs 6.6 (RAYtech machine KV37, USA). A trained tech-
nician blinded to the infection status of the mice examined
the X-rays, which were scored for signs of lung injury: 0, no
change; 1, discrete and/or light opacification; and 2, diffuse
opacification.The mice were later classified as suffering from
ALI/ARDS or HP at death by the presence or absence of
pleural effusion, respectively.
2.6. Determination of Respiratory Pattern. Respiratory pat-
terns (respiratory frequency (RF) and enhanced pause
(Penh)) were monitored on the 5th, 7th, 9th, 15th, and 20th
DAI by placing the mice in an unrestrained whole-body
plethysmography chamber (WBP, Buxco Electronics, Wilm-
ington, North Carolina, USA) for 10 minutes (basal level).
The data were collected using Biosystems XA software and
included the RF (breaths/minute) and variables to calculate
the Penh, a theoretical variable that correlates with both pul-
monary resistance and intrapleural pressure [21].The Penh is
calculated by [22]
Penh = peak expiration speed
peak inspiration speed
× (
expiratory time
relaxation time
− 1) .
(1)
2.7. Identifying ALI/ARDS in Mice before Death. To identify
ALI/ARDS in mice before death, we used two groups of
infected mice: the survival group (infected control) and the
sacrificed group in which the mice were sacrificed on the
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7th DAI (10–12 mice per group). In the survival group, any
mouse showing pleural effusion or red and congested lungs
at necropsy, the cause of death was attributed to ALI/ARDS.
In contrast, at necropsy, in mice without pleural effusion
that died after 13th DAI with pale lungs and high levels of
parasitemia, the cause of death was attributed to HP and
consequently anemia.
Individual mice sacrificed on the 7th DAI were classified
as having been likely to die ofALI/ARDSorHP, by comparing
their respiratory patterns and parasitemia levels with the
survival group, inwhich the causamortiswas known (Supple-
mentary Figure S1 in SupplementaryMaterial available online
at http://dx.doi.org/10.1155/2014/872464).
In each individual experiment, using the survival group,
we established three cut-offs using receiver operating char-
acteristic (ROC) curves for the Penh, RF, and parasitemia
measured on the 7th DAI, which were used as predictive
criteria. The cut-offs from this group were chosen based on
the maximum sensitivity and specificity for each parameter.
The mice sacrificed on day 7 were also screened for the
same parameters before sacrifice, and they were grouped
based on the cut-offs from the ROC curves generated using
data from the survival group. The same cut-offs were used
to retrospectively classify the sacrificed group as suffering
from ALI/ARDS or HP. The mice were said to have suffered
from ALI/ARDS if they were above the cut-off for at least
two of the three variables. For this method to work, it was
necessary that three or more animals died by ALI/ARDS in
the survival group/per experiment. In all of the experiments,
we calculated the sensitivity and specificity from the survival
group.
2.8. Confirming the Accuracy of the Groupings. To confirm if
and when the mice could be grouped using the respiratory
pattern cut-offs and parasitemia, confirmation experiments
were performed. Two survival groups were assessed for
pleural effusion and reddish lungs, which were used as the
gold standards for mice dying of lung injury. These criteria
constitute a practical phenotype for assessing ALI/ARDS
because they are not arbitrary and can be assessed imme-
diately during the necropsy; furthermore, previous results
have shown that 100% of the mice that die between 7–12 DAI
with clear signs of ALI, including the presence of pulmonary
edema, hemorrhages, and hypoxemia [14]. The survivors
were monitored until the 20th DAI, and the cause of death
was determined. At the end of the experiment, the data from
one group were used to generate the ROC curves that were
then used to classify the mice in the second group on the
7th DAI; these results were then compared with observa-
tions of the pathology from necropsy of the second group
(Supplementary Figure S2). Confirmation that the second
mouse groupings were likely to be correct was performed
in experiments in which the sensitivity and specificity of the
groupings using the ROC curves were calculated.
2.9. Lung Permeability and Edema. To investigate lung per-
meability, on the 7th DAI, mice were injected intravenously
with 0.2mL of 1% Evans Blue (Sigma). The mice were
sacrificed 45 minutes later, and the lungs were weighed and
placed in 2mL of formamide (Merck) for 48 hours at 37∘C.
The absorbance of the formamide was then measured at
𝜆620 nm.The amount of Evans Blue staining per gramof lung
tissue was calculated from a standard curve. The sacrificed
mice were classified as suffering from ALI/ARDS by the
ROC curves generated from a survival group as described
above. The lung permeability of the ALI/ARDS and HP mice
was expressed as fold increase in relation to that of the NI
mice. To further investigate the presence of edema, in a
group of survival mice, the lungs were weighed immediately
after natural death, and the wet weights were recorded and
compared between ALI/ARDS and HP mice of the same age.
The mice were confirmed as suffering from ALI/ARDS or
HP at death by the presence or absence of pleural effusion,
respectively.
2.10. VEGF in Serum. On the 7th DAI, mice were anesthe-
tized, and their serum was collected by cardiac puncture. An
ELISA kit (R&D Systems) was used to quantify VEGF levels
in the serum according to the manufacturer’s instructions.
TheVEGF level of theALI/ARDS andHPmicewas expressed
as fold increase in relation to that of the NI mice. The
mice were classified as suffering from ALI/ARDS or HP by
comparing the predictive criteria and VEGF levels.
2.11. Hematological Parameters Determination. Blood sam-
ples were collected in tubes containing sodium citrate as anti-
coagulant. Total number of red blood cells, hemoglobin, and
hematocrit were measured using V-53 reagent kit (Mindray,
P.R. China) and Auto Hematology Analyzer BC-5300Vet
(Mindray, Nanshan, Shenzhen, P.R. China).
2.12. Statistical Analysis. The data were analyzed by D’Agost-
ino-Pearson normality test. Nonparametric variables were
compared using Mann-Whitney test. The simultaneous
effects of two factors were analyzed by two-way ANOVA fol-
lowing Bonferroni post-hoc test.The differences between the
groups were considered significant when 𝑃 ≤ 0.05. Statistical
analyses were performed in GraphPad Prism version 5.0,
including assessments of sensitivity and specificity. To estab-
lish cut off from data, ROC curves were generated using the
results of the control group in MedCalc version 8.2.1.0. The
Penh, RF and, EPdatawere analyzed using SPSS forMicrosoft
version 19.0 through a Pearson correlation (Penh versus RF:
−0.827, 𝑃: 0.001; Penh versus EP: −0.152, 𝑃: 0.001; RF versus
EP: 0.200, 𝑃: 0.05) for further grouping. The cluster analysis
was developed by case grouping using Ward’s method with a
Euclidean distance analysis, which generated a dendrogram
grouping each of the subjects studied and their physiologic
characteristics analyzed into a particular cluster.
3. Results
3.1. Overview of Pathology at Death in PbANKA-Induced
ALI/ARDS. To characterize and discriminate the pathology
associated with ALI/ARDS or HP, DBA/2 mice were infected
with P. berghei ANKA-infected red blood cells (iRBCs) and
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followed until their deaths. Subsequently, the animals were
necropsied and the causa mortis determined. Survival anal-
ysis revealed an average of 49.2% (25–75%) of the mice had
died of ALI/ARDS between the 7th and 12th DAI, whereas
theHPmice died between the 13th and 21st DAI (Figure 1(a)).
Although parasitemias were increased in both groups, theHP
group had higher levels of parasitemia, at approximately 40–
50% on the day of death (Figure 1(b)). Comparing the lung
weights, we observed that the mice that died with ALI/ARDS
had heavier lungs (averaging 40% more mass) than the mice
that died with HP, suggesting edema (Figure 1(c)).
At necropsy, noninfected (NI) mice had light pink lungs,
and no liquid inside of the thoracic cavity was observed
(Figure 1(d)). However, mice that died with ALI/ARDS
had reddish lungs and pleural effusion (Figure 1(e)). In
these mice, the histological changes where characterized by
marked alveolar edema and hemorrhage, along with neu-
trophil-dominant inflammatory cellular infiltration, foamy
macrophages in the alveolar and interstitial sites, and
destruction of the alveolar septa (Figure 1(h)), as previously
described [14]. In contrast to the ALI/ARDS mice, the
animals that died with HP after the 13th DAI had grayish
lungs and a darkened spleen and liver but no pleural effusion
(Figure 1(f)) and severe anemia, with decreases in the number
of erythrocytes, hemoglobin level, and hematocrit percentage
(Supplementary Figure S3). These HP mice had interstitial
pneumonia with mononuclear inflammatory cells but at a
later time in the infection, diagnosed on the day of death
(Figure 1(i)). Interestingly, in the lungs of ALI/ARDSmice we
observed the presence of acellular eosinophilic membranes
that adhered to the alveolar ducts and walls and hyaline
membranes, a hallmark of ALI/ARDS in humans (Figures 1(j)
and 1(k)).
3.2. Chest Radiography Shows Lung Opacity in PbANKA-
Induced ALI/ARDS. Bilateral infiltrates observed on frontal
chest radiographs are recognized as a criterion for the diag-
nosis of ALI and ARDS [23]. In our work, X-ray analysis
on the 7th DAI revealed lung opacification, which was more
prominent in the ALI/ARDS group than in the HP group
(Figures 2(a) and 2(b)). NI mice had no changes in the lungs.
3.3. PbANKA-Induced ALI/ARDS Is Associated with Hypox-
emia and Decreased Body Temperature. Hypoxemia is not a
direct assessment of damage per se but is often a manifes-
tation of injury [24]. In humans, the hypoxemia was
defined by The American-European Consensus Conference
as PaO
2
/FiO
2
≤ 300mmHg (for ALI) or ≤200mmHg (for
ARDS) [25]. In agreement with previous results [14], we
show that the majority of the DBA/2 mice infected with
PbANKA who died of ALI/ARDS had PaO
2
/FiO
2
values
between 200 and 300mmHg, and we further demonstrate
that mice that developed the more severe form of ARDS,
presented PaO
2
/FiO
2
values of ≤200mmHg. On the 7th DAI,
the PaO
2
/FiO
2
in the ALI/ARDS group (234.3 ± 21.38) was
significantly lower than the level in theHP group (303±17.26;
𝑃 = 0.029) (Figure 2(c)). NI mice showed PaO
2
/FiO
2
values
above 300mmHg with average 371.42 (SD ± 24.27).There are
no agreed-upon validated PaO
2
/FiO
2
data in animal models
of lung injury [26]; thus, we categorized all of the animals in
the group with lung injury as ALI/ARDS.
The infected mice had slightly increased body tempera-
tures between day 0 and the 5th DAI; however, between the
7th and 9th DAI, their temperatures dropped and the mice
became hypothermic (Figure 2(d)). Mice that would start to
develop ALI/ARDS and die had the lowest temperatures on
the 7th DAI compared with the HP mice. We hypothesized
that the reduction in body temperature could be related
to decreased survival of the animals, especially those that
developed ALI/ARDS.
3.4. Respiratory Patterns and Parasitemia Are Correlated
in PbANKA-Induced ALI/ARDS. To characterize the lung
physiopathology during infection, we analyzed the enhanced
pause (Penh), respiratory frequency (RF), and parasitemia
(EP) levels at five different time points. On the 5th DAI the
ALI/ARDS group had breathing patterns and parasitemia
similar to the HP group and NI mice. However, by the 7th
DAI, the ALI/ARDS group had increased Penh, decreased
RF, and a tendency to increase the parasitemia even if not
significantly, compared with the HP mice (Figures 3(a)–
3(c)). After the 9th DAI, the statistical comparison between
the ALI/ARDS and HP mice could not be performed in
the individual experiments due to the minimal numbers
of surviving ALI/ARDS mice. Interestingly, animals that
survived for longer periods, that is, animals that did not
develop ALI/ARDS and subsequently died by HP, breathing
patterns returned nearly to baseline levels. NI mice had no
changes in breathing patterns over time.
Parasitemia increased over the course of infection
(Figure 3(c)). On the day of death, parasitemia in the ALI/
ARDS groupwas 20.8% (SD ± 4.6), while parasitemia inmice
that died of HP was 40.9% (SD ± 9.21; 𝑃 ≤ 0.0001). However,
on the 7thDAI, themice thatwent on to die ofALI/ARDShad
17.0% (SD± 5.0) iRBCs, while themice that would go on to die
with HP were 12.2% (SD ± 4.5) parasitemic (Supplementary
Figure S4a).
Aiming to perform a correlation study examining the res-
piratory parameters (Supplementary Figure S4b and S4c) and
EP (Supplementary Figure S4a), we conducted experiments
on the 7th DAI, when the onset of important pulmonary
pathology occurred, rather than using the 5th DAI when we
did not observe consistent differences in respiratory patterns
between the study groups.
The high correlation between Penh, RF, and EP and the
development of ALI/ARDS or HP (Pearson correlation Penh
versus RF: −0.827, 𝑃 = 0.001; Penh versus EP: −0.152, 𝑃 =
0.001; RF versus EP: 0.200, 𝑃: 0.05) led us to identify four
groups based on the cluster analysis (group 1 consisted of
88.46% of individuals with ALI/ARDS and 11.53% with HP;
group 2 included 57.77% of individuals with ALI/ARDS and
42.22%withHP; group 3 consisted of 19.35% individuals with
ALI/ARDS and 80.64% with HP; group 4 included 21.42% of
individuals with ALI/ARDS and 78.57% with HP) (Figure 4).
Such clustering highlights that the physiological conditions
evaluated in groups 1 and 2 were dominated by ALI/ARDS,
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Figure 1: Infection of DBA/2 mice with P. berghei ANKA constitutes a rodent model for malaria-associated ALI/ARDS. (a) Survival and
(b) parasitemia curves from the ALI/ARDS and HP mice over time. The red line was the mice that died with ALI/ARDS. The gray area
represents the period when the mice die of ALI/ARDS. The data presented are representative of 13 independent experiments; 𝑛 = 10–12
mice/experiment. (c)The lungs of mice that died with ALI/ARDS weighed 40%more than the lungs of mice that died with HP (∗∗𝑃 ≤ 0.005;
Mann-Whitney test of lung weights are representative of four separate experiments). Data ((b) and (c)) represent means and SEM; 𝑛 = 10–12
mice/experiment. (d) Representative pictures of a NImouse, (e) an infectedmouse that died with ALI/ARDS showing hemorrhagic lungs and
a large amount of pleural effusion, and (f) a mouse that died with HP showing pale and grayish lungs and no pleural effusion. Representative
histopathological images of lungs from (g)NImice and infectedDBA/2mice that diedwith (h)ALI/ARDS and (i)HP on the 10th and 21st days
after infection, respectively. The arrow points to the hyaline membranes in the lungs of the DBA/2 mice that died with (j) ALI/ARDS stained
with hematoxylin-eosin and (k) stained with phosphotungstic acid hematoxylin. The bar corresponds to 100𝜇m. HP: hyperparasitemia;
ALI/ARDS: acute lung injury/acute respiratory distress syndrome.
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Figure 2: Radiography of the lungs, hypoxemia, and body temperature over time. (a) From left to right, X-rays from NI and infected DBA/2
mice that died with ALI/ARDS and HP showing different lung opacification scores on the 7th DAI. (b) Lung opacification scores on the
7th DAI. Mice that will later die with ALI/ARDS have a higher lung opacification score compared with mice that will die with HP (𝑛 = 12;
∗
𝑃 ≤ 0.05, Mann-Whitney test of scores taken from two separate experiments). NI mice do not have any lung opacification and are assigned
score zero. (c) PaO
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values in P. berghei ANKA-infected mice on the 7th DAI. Results from three grouped experiments (𝑛 = 13 mice,
∗
𝑃 ≤ 0.05; Mann-Whitney test). (d) Body temperatures in DBA/2 mice infected with P. bergheiANKA slightly increased on the 5th DAI from
37.1∘C in the NI mice to 37.3 in the ALI/ARDS mice and 37.4∘C in the HP mice). However, the temperatures dropped and the mice became
hypothermic (especially the ALI/ARDS mice), with mean temperatures of 33.0∘C on the 7th DAI and 32.8∘C on the 9th DAI. Results are
from three grouped experiments (𝑛 = 31 mice; ∗∗∗𝑃 ≤ 0.001, two-way ANOVA with Bonferroni post test). Data (d) represents means and
SEM. The dashed line represents the mean value of NI mice. NI: noninfected mice; ALI/ARDS: acute lung injury/acute respiratory distress
syndrome; HP: hyperparasitemia.
while groups 3 and 4 were dominated byHP, with a difference
of 25%. Additionally between the groups with major higher
frequencies of one of the two pathologies (groups 1 and 2 or
groups 3 and 4), the difference between the analyzed char-
acteristics was 10%.
3.5. AMurineModel to Predict Malaria-Associated ALI/ARDS
at an Early Time Point. Mice that die from ALI/ARDS
present altered Penh, RF, and EP values from the mice that
die from HP; thus, we hypothesized that those parameters
could be used as predictive criteria for the causa mortis. As
described in the materials and methods, for each individual
experiment, we used an infected control group (survival
group) and established cut-offs using ROC curves for Penh,
RF, and EP (Supplementary Table S1) measured on the 7th
DAI and applied these cut-offs to classify the sacrifice group
(Supplementary Figure S1). Following this procedure, the
mice sacrificed on the 7th DAI could be classified as likely
to die with ALI/ARDS or HP. We compared their respiratory
patterns and parasitemia with a survival group that was not
sacrificed and for which the cause of death was known. The
sensitivity (≤100% and ≥67%; average 88.31%; SD ± 11.95) and
specificity (100% ≤ and ≥71%; average 90.85%; SD ± 10.81)
were calculated from the survival group for each individual
experiment. In addition, we observed that the respiratory
patterns and parasitemia were similar between the survival
group and the sacrificed group (Figures 5(a)–5(c)).
To confirm the accuracy of the grouping, the cut-offs
from the ROC curves of the respiratory patterns and para-
sitemiawere performed using the two infected control groups
(survival groups) on the 7thDAI.The groups weremonitored
until the 20th DAI, and the cause of death was determined
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9th DAI that the ALI/ARDS and HPmice had different breathing patterns. However, on the 7th DAI, there was evidence that the ALI/ARDS
mice had a higher enhanced pause (Penh) (a) and a lower respiratory frequency (b) than the HP mice. Parasitemia increased over time in
both groups (c). Results are representative from three independent experiments (𝑛 = 11 mice/experiment; ∗𝑃 ≤ 0.05, two way ANOVA
with Bonferroni post test). The dashed line represents the mean value of NI mice; NI: noninfected mice; ALI/ARDS: acute lung injury/acute
respiratory distress syndrome; HP: hyperparasitemia.
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Figure 4: Breathing patterns and parasitemia could be used to
group mice into two main clusters. Ward’s linkage cluster analysis
illustrates the distance between the physiological cluster patterns
in DBA/2 mice infected with P. berghei ANKA that developed
ALI/ARDS and HP. Values were measured on the 7th DAI.The data
are from 13 independent experiments; 𝑛 = 142 mice. Group 1 =
88.46% of individuals with ALI/ARDS and 11.53% with HP; group 2
= 57.77% of individuals with ALI/ARDS and 42.22% with HP; group
3 = 19.35% individuals with ALI/ARDS and 80.64% with HP; group
4 = 21.42% of individuals with ALI/ARDS and 78.57% with HP.
ALI/ARDS: acute lung injury/acute respiratory distress syndrome;
HP: hyperparasitemia.
(Supplementary Figure S2). On the 7th DAI, we were able
to group the mice in the ALI/ARDS or HP groups with
91% sensitivity and 76% specificity in the three grouped
experiments (Table 1). Among the experiments, the best result
was 100% sensitivity and 100% specificity, and the worst result
was 66.6% sensitivity and 60% specificity. On the 9thDAI, we
were not able to group the mice, as no ALI/ARDS mice from
the survival group were alive.
3.6. PbANKA-Induced ALI/ARDS Causes Breakdown of the
Alveolar-Capillary Barrier. In a previous study, we demon-
strated that VEGF promotes malaria-associated ALI in mice
Table 1: Confirming the accuracy of the groupings. True and false
pathologies checked by the ROC curves from the predictive criteria∗
on the 7th DAI and the causa mortis.
Pathology
Test ALI/ARDS HP Total
Hits 11 13 24
Errors 1 4 5
Total 12 17 29
∗Penh, respiratory frequency, and parasitemia.
and that expression of this growth factor is increased in
mice that died of ALI [14]. Here, using blood samples
from mice sacrificed on the 7th DAI, we confirmed that
mice classified as likely to die with ALI/ARDS and HP had
VEGF serum levels 3.3-fold and 1.7-fold higher than those
in the NI group, respectively (Figure 6(a)). Furthermore, the
pulmonary vascular permeability measured by Evans blue
uptake in the lungs on the 7th DAI was higher in mice
predicted to die of ALI/ARDS (10.6-fold higher thanNImice)
than in those classified as suffering from HP (5.5-fold higher
than NI mice) (Figures 6(b)–6(e)).
4. Discussion
According to The American-European Consensus Confer-
ence, the recommended criteria to define bothALI andARDS
are acute onset, hypoxemia levels of PaO
2
/FiO
2
≤ 300mmHg
(for ALI) or≤200mmHg (for ARDS), bilateral infiltrates seen
on a frontal chest radiograph, and pulmonary artery wedge
pressure (≤18mmHg when measured or no clinical evidence
of left atrial hypertension) (revised by Thompson and Moss,
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Figure 5:Amurinemodel to predictmalaria-associatedALI/ARDS. (a) Penh (enhanced pause), (b) respiratory frequency, and (c) parasitemia
measured on the 7th DAI. The sacrificed mice were classified according predictive model, using the parameter cut-offs measured from the
survival mice and applied to the sacrificedmice. DBA/2mice infected with P. bergheiANKA and their breathing parameters weremeasured in
plethysmograph chambers (BUXCOElectronics, USA). Note that these three parameters are similar between the survival group and sacrificed
group; (𝑛 = 11mice/group; ∗𝑃 < 0.05, ∗∗𝑃 < 0.005, Mann-Whitney test). ALI/ARDS: acute lung injury/acute respiratory distress syndrome;
HP: hyperparasitemia; bpm: beats per minute. Results are representative of more than 5 independent experiments.
2010). Recently, in accord withThe Berlin Definition, the ALI
term was abolished and the ARDS was defined based on oxy-
genation:mild ARDS (200mmHg PaO
2
/FiO
2
≤ 300mmHg),
moderate ARDS (100mmHg PaO
2
/FiO
2
≤ 200mmHg), and
severe ARDS (bellow 100mmHg PaO
2
/FiO
2
, among other
criteria [27]. However, The Berlin Definition was not vali-
dated by a later study [28] and ALI is still used for lung injury
in mice. Despite the discussion in the field, some consensual
parameters are used to study ALI in mice such as kinetics
of injury, radiographic evaluation, physiological assessment,
histological evidence of lung injury, and assessment of
increased permeability of the alveolar-capillary membrane
[26].
Malaria-associated ALI/ARDS is progressively more fre-
quently reported, is often fatal and is still not fully understood
[29], thus an animal model would be essential to address
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Figure 6: Increased vascular permeability and serum VEGF protein confirmed the predictive criteria for malaria-associated ALI/ARDS. (a)
Serum VEGF protein in DBA/2 mice infected with P. berghei ANKA on the 7th DAI was measured by ELISA. The VEGF levels are higher in
the mice classified as likely to die with ALI/ARDS compared with HPmice (according to the proposed predictive criteria).The data represent
fold increases in relation to NI mice taken from three experiments; (𝑛 = 28 mice; ∗∗𝑃 < 0.005, Mann-Whitney test). (b) Lung vascular
permeability in DBA/2 mice infected with P. berghei ANKA 7th DAI, assessed using Evans Blue. The vascular permeability is higher in the
mice classified as likely to die with ALI/ARDS compared with the HPmice (according to the proposed predictive criteria).The data represent
fold increased in relation to NI mice taken from three experiments; (𝑛 = 51 mice; ∗𝑃 < 0.05, Mann-Whitney test). Bars represent means
and SEM.The images represent (c) NI: noninfected mice, (d) ALI/ARDS: acute lung injury acute respiratory distress syndrome, and (e) HP:
hyperparasitemia.
such a complex disease [30]. We showed that DBA/2 mice
infected with PbANKA constitute a rodent model of malaria-
associated ALI/ARDS [14], and here, we approach respiratory
and parasitological parameters to devise a mathematical
model able to predict development of ALI/ARDS during
PbANKA infection.
This murine model clearly showed edema in ALI/ARDS
mice, indicating that these animals had more severe disease
and that they were dying during the exudative phase of
ALI/ARDS. In addition, we observed local destruction of the
alveolar epithelium, with denuded areas covered by fibrin-
containing hyaline membranes, a hallmark of ALI/ARDS in
humans [23], along with neutrophils, alveolar macrophages,
mononuclear cells, and iRBC. The presence of edema
observed in the ALI/ARDS mice is also reflected by the
increased wet weight of the lungs [31], although the increased
weight of the lungs could be partially due to cellular accu-
mulation [18]. The opaque appearance of the lungs in X-rays
and the opaque pulmonary alveolar pattern were sometimes
bilateral and other times unilateral. However, we did not
observe type II cell hyperplasia in the ALI/ARDS mice or the
interstitial fibrosis characteristic of the proliferative phase of
ARDS, denoting the early stage of the acute syndrome.
Pleural effusion was used as a gold standard for mice
dying of lung injury, as it is a practical nonarbitrary pheno-
type to assess. Even though this finding is infrequent in
humanmalaria, pleural effusion has been observed in malar-
ia-associated ARDS in humans and in a nonmalarial setting
andhas previously been correlatedwith reduced gas exchange
in the lungs [32–34].
Here, we showed that respiratory patterns and parasite-
mia differ between the mice that would go on to die with
ALI/ARDS or HP in a model of malaria-associated lung
injury. We further show that we could use these differences
to accurately group the mice as likely to die with ALI/ARDS
as early as the 7th DAI but not on the 5th DAI. On the 7th
DAI, there were significant differences in these parameters
between the two groups, and the use of a cut-off from the
ROC curves enabled us to identify the mice that would die
with ALI/ARDS, with 88.5% (SD ± 11.52) sensitivity and
90.7% (SD ± 11.45) specificity at this point using the cut-off
for Penh, RF, and EP from the survival group as a template
for the sacrificed group.
The ability to identify mice as being likely to die of
ALI/ARDS accurately based on respiratory patterns and par-
asitemia opens up the possibility of studying this disease
without concerns for confounding data generated from mice
that would never go on to develop the disease or having to
wait until death is imminent. Altered respiratory patterns
are associated with lung injury and have been observed in
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a number of respiratory models, including Penh data that
have been used in different murine models [35–37]. The high
parasitemia that is associated with adverse outcomes has
been shown in a number of murine malaria models [38, 39],
further supporting our choice to use these parameters to
distinguish mice suffering from ALI/ARDS. Despite some
controversy regarding the use of Penh [20], our results clearly
show that this parameter varies betweenmice that will or will
not die of ALI/ARDS.
ARDS in humans causes tachypnea [23]. Nevertheless,
the current data showed the ALI/ARDS mice had a lower
RF than the HP mice. In addition, our results showed that
animals with ALI/ARDS experienced a sharp decline in body
temperature, especially on the 7th DAI. Despite malaria
being traditionally known as a febrile illness [40, 41], murine
malaria, including ARDS, can lead to hypothermia [18, 42,
43]. This symptom may be an interesting effort to reduce
inflammation-mediated damage to the endothelium, as it has
been shown that increased temperatures result in increased
sensitivity of endothelial cells to proinflammatory factors
such as tumor necrosis factor [44].We suggest that decreased
RF may be a side effect of hypothermia; it may also be
associated with the increased effort required by the mice to
breathe due to the lung damage, edema and/or hypothermia
that may have contributed to the development of ALI/ARDS
and the death of these animals.
Even though the parasitemia average was higher in the
ALI/ARDS group on the 7th DAI in the 13 experiments
observed (Supplementary Figure S4a), it was the most vari-
able analyzed parameter. In our predictive model, even small
differences often helped to define whether an animal would
be classified with ALI/ARDS or HP because the proposed
method combines two or three parameters at the same time.
The high correlation identified between the Penh, RF, and
EP and the development of ALI/ARDS or HP exhibited
in the development of these pathologies by cluster analysis
(Figure 4) with any differentiation factors studied under 5%
could allow a positive identification of ALI/ARDS with an
accuracy varying from 57.77% to 88.46% or of HP with an
accuracy varying from 78.57% to 80.64%. Furthermore, these
experiments revealed a large difference in these variables
between the groups ranging from 25% to 10% in terms of
physiological conditions studied, enabling us to establish
parameters to predict the presence or absence of ALI/ARDS
or HP with greater accuracy in our study model either with
a refinement of the data or with the inclusion of one or more
variables.
Previously, it was shown that lung vessel permeability and
VEGF levels were significantly higher in infectedDBA/2mice
exhibiting ALI symptoms when death is imminent [14]. Here,
we confirmed similar these results using this new predictive
criteria to classify these mice.
How Plasmodium infection causes ALI/ARDS remains
largely unknown. Animal models have the potential to eluci-
date themechanisms of disease and identify prognosticmark-
ers and therapeutic targets. The results presented in this
paper describe a murine model of ALI/ARDS and, most
importantly, describe how it is possible to accurately identify
mice with lung injury before death.The study of mechanisms
involved in the genesis of ALI/ARDS on earlier time points
is essential for the elucidation of the pathogenic events
underlying the development of this severe disease.
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